Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

The aging US population is predicted to drive an increase in cancer incidence of almost 50% by 2050. At the same time, some cancer programs face capacity and resource constraints—which will continue to increase as demand for cancer services rises. Many cancer programs are also facing significant challenges with patient access.
As CAR T-cell therapies provide new treatment options for patients with certain hematologic malignancies, it is important that more cancer centers and programs deliver them.
The Association of Community Cancer Centers (ACCC) today announced the release of its new consensus-based Oncology Financial Advocacy Services Guidelines, a comprehensive framework developed to aid cancer programs and practices deliver services to patients that prevent, detect and mitigate financial hardship during cancer care.
Multiple Myeloma: BCMA-Targeted Therapies for Relapsed/Refractory Multiple Myeloma MODERATOR Dr. Cristina Gasparetto Duke University targetedonc.com/events Register Today In this discussion, we will discuss two clinical cases that will cover relapsed, refractory multiple myeloma and potential treatment options. Join Targeted Oncology™ for a collaborative, small- group meeting …
BCMA-Targeted Therapies for Relapsed/ Refractory Multiple Myeloma MODERATOR Dr. Douglas Weston Sborov University of Utah, Huntsman Cancer Institute targetedonc.com/events Register Today In this discussion, we will discuss two clinical cases that will cover relapsed, refractory multiple myeloma and potential treatment options. Join Targeted Oncology™ for a collaborative, …
TxSCO Monthly Update 2023-11-09 Nov. 9, 2023 TxSCO Update Overview: Notable Updates 2 Federal • E&C MACRA hearing + Dr. Patt’s testimony • Final Rules: PFS, OPPS, 340B • EOM Updates • Speaker update State • Special sessions update • COVID Vax mandate prohibition • Retirements • State Budget Update Dr. Patt Testifies at House …
TACOS ONCOLOGY DRUG NEWSLETTER N O V E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Pembrolizumab (Keytruda) The FDA has approved perioperative pembrolizumab (Keytruda) in combination with platinum-containing chemotherapy as neoadjuvant treatment …
TxSCO ONCOLOGY DRUG NEWSLETTER N O V E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Pembrolizumab (Keytruda) The FDA has approved perioperative pembrolizumab (Keytruda) in combination with platinum-containing chemotherapy as neoadjuvant treatment …
NCOA ONCOLOGY DRUG NEWSLETTER N O V E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Pembrolizumab (Keytruda) The FDA has approved perioperative pembrolizumab (Keytruda) in combination with platinum-containing chemotherapy as neoadjuvant treatment …
SCOS ONCOLOGY DRUG NEWSLETTER N O V E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Pembrolizumab (Keytruda) The FDA has approved perioperative pembrolizumab (Keytruda) in combination with platinum-containing chemotherapy as neoadjuvant treatment …
Innovations in Nursing Care Models Innovations in Nursing Care Models Linda Alderson MSN, RN, NEA-BC Chief Nurse Executive MultiCare Tacoma General & Allenmore Hospitals WSMOS Conference 11/17/2023 Nursing Projections 3,495,014 4,450,788 - 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 3,500,000 4,000,000 …
Navigating Workforce Challenges in Healthcare Moderator: Ray Page, DO, PhD, FACOI, FASCO; The Center for Blood and Cancer Disorders Anthony Back, MD; Cambia Palliative Care Center of Excellence, University of Washington, Seattle Amy Ellis, COO, Northwest Medical Specialties, PLLC The State of Professional Well-being and Satisfaction Among U.S. Oncologists ASCO Quality …
PowerPoint Presentation Strategies for Managing the Tsunami of Medical Information: AI and Beyond David R. Penberthy, MD MBA Associate Professor Penn State College of Medicine Medical Director of Radiation Oncology Milton S. Hershey Medical Center President, ACCC 2022-2023 November 17, 2023 Disclosures Opinions are my own I would like to acknowledge …
Targeted Oncology’s Seating is limited, and registration will close when capacity is reached. Reserve your seat today! Myeloproliferative Neoplasms: Myelofibrosis and Polycythemia vera MODERATED BY Raajit K. Rampal, MD, PhD Biomarker Testing & Targeted Therapy in Advanced/ Metastatic NSCLC MODERATED BY Nicholas Rohs, MD Stay informed on the latest research data in an …
November 11, 2023
In this workshop, provided by the France Foundation, interactive formats will allow the multidisciplinary care team to continuously assess knowledge gaps.
Non-Cognitive Predictors of Student Success: A Predictive Validity Comparison Between Domestic and International Students The first oncology-focused, Age-Friendly Health Systems action community helped 22 cancer programs implement the 4Ms framework to organize care and focus on the older adult’s wellness and strengths rather than solely on disease. Non-Cognitive Predictors of Student …
This is a visual representation of an online publication from the Gerontological Society of America Annual Scientific Meeting, November 8-12, 2023.Learn more about the GSA Annual Scientific Meeting.
Health technology performance and integration of electronic health record (EHR) systems have become critical factors in conducting efficient and equitable biomarker testing at cancer programs nationwide.. Listen in as CancerBuzz speaks to Karen Huelsman, MS, LGC, precision oncology lead and genetic counselor at TriHealth Cancer and Blood Institute, about key takeaways and insights from the Working …
November 10, 2023
Topic: A Case-Based Roundtable Meeting on Challenging Cases of Relapsed/Refractory Multiple Myeloma You're invited to participate in our upcoming Case-Based Roundtables, an exclusive and collaborative event tailored to enhance your expertise in the field of oncology. This unique session revolves around case-based clinical profiles, offering a platform for peer dialogue, and is expertly moderated …